Optimising Anticoagulation For Stroke Prevention in Patients with NVAF – Part 2

Thursday, 17 June, 2021 20:00-21:00

Part 2: Switching from Warfarin to a NOAC

An interactive discussion on the latest recommendations for practical management of anticoagulation in patients with NVAF

Speaker: Lynne Garforth


  • Case study: following a patient who is switched from warfarin to apixaban
  • Key changes in the latest 2021 NICE guidance
  • The use of ORBIT as a bleeding risk score tool
  • DOACs as first-line treatment for newly diagnosed patients with NVAF

To discuss the option of switching to a DOAC in patients with NVAF who are already taking a VKA and are stable.

Book your place here

View all events >

HEE: Advanced Practice Webinar

Health Education England (HEE) North West have organised a free webinar that will place via Microsoft Teams on Tuesday 16th...

Novo Nordisk: PenCycle Launch

Over the past year Novo Nordisk have been engaging with Greater Manchester LPC in order to work on the PenCycle...

CPCS IT Webinar

NHSE&I, with the support of PSNC, is planning to hold a webinar on the 14th of October, from 7.00-8.30pm, to help contractors prepare for...